Effective depletion of alloreactive lymphocytes from peripheral blood mononuclear cell preparations

Citation
L. Garderet et al., Effective depletion of alloreactive lymphocytes from peripheral blood mononuclear cell preparations, TRANSPLANT, 67(1), 1999, pp. 124-130
Citations number
39
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
TRANSPLANTATION
ISSN journal
00411337 → ACNP
Volume
67
Issue
1
Year of publication
1999
Pages
124 - 130
Database
ISI
SICI code
0041-1337(19990115)67:1<124:EDOALF>2.0.ZU;2-2
Abstract
Background. T cells present in an allogeneic bone marrow transplant may pro duce graft-versus-host disease but also contribute to immune reconstitution and enhance engraftment. Our aim was to separate alloreactive from nonallo reactive T lymphocytes, by performing a mixed lymphocyte culture (MLC) stim ulation of donor cells, followed by selective depletion of activated cells expressing the high-affinity interleukin 2 receptor. We then characterized the resulting depleted cell fraction. Methods. Donor peripheral blood mononuclear cells were cocultured with irra diated peripheral blood mononuclear cells from HLA-nonidentical recipient s timulators in an MLC. After 3 days, CD25(+) lymphocytes (alloreactive cells expressing the alpha chain of the interleukin 2 receptor) were removed by immunomagnetic separation. The depleted donor fraction and untreated cells were then rechallenged in a secondary MLC with the original irradiated stim ulator cells or a third party to assess relative alloreactivity. Results. Inhibition of the secondary MLC and of host-specific cytotoxic act ivities was observed as well as a disappearance of interleukin 2 receptor-p ositive cells. Alloreactivity against unrelated third-party cells was prese rved. Limiting dilution analysis of residual alloantigen-reactive T lymphoc ytes demonstrated a 1.3 log reduction of antihost reactivity, The depletion largely removed host-specific alloreactive CD4(+) cells. Conclusions. This method reduces alloreactivity while retaining reactivity against third-party targets. This approach may allow therapeutic infusion o f T cells after HLA-nonidentical allografts with a reduced capacity to prod uce graft-versus-host disease.